27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Argus's David Coleman upgraded Chemours Co (NYSE: CC) to Buy with a $13.00 price target.
"We believe that Chemours has significant competitive advantages based on its large size, vertically integrated structure, and broad geographic reach," said Coleman. The company had shown strength by cutting costs and raising prices while improving working capital, according to the analyst.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Additionally, Coleman appreciated the CEO's positive comments on Chemours' recent transformation plan while projecting higher EBITDA and "modestly positive" free cash flow in FY16.
In response to Chemours' recent signs of strength, Argus raised the company's 2016 diluted EPS estimate from $0.75 to $0.83 and FY17 estimate from $1.087 to $1.16. Both estimates are above the analyst average.
According to TipRanks, Coleman has a 65 percent success rate and a +2.4 percent average return per recommendation.
At time of writing, Chemours traded at $10.67, up 3.59 percent.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.